IPAC2011 - List of Authors (Franzini, G.)

Paper	Title	Page
MOPO039	B-train Performances at CNAO	568
	M. Pezzetta, G. Bazzano, E. Bressi, L. Falbo, C. Priano, M. Pullia CNAO Foundation, Milan, Italy O. Coiro, G. Franzini, D. Pellegrini, M. Serio, A. Stella INFN/LNF, Frascati (Roma), Italy G. Venchi University of Pavia, Pavia, Italy
	The commissioning of CNAO, the Italian Centre of Oncological Hadrontherapy, with proton beams is completed. The real-time measurement of the synchrotron dipole field with the so-called B-train, together with its electronic systems and related software and firmware are here described. An additional magnet, powered in series with the synchrotron dipoles, is equipped with a special coil that measures the field integral variation along the beam nominal path. The voltage induced in the coil is digitized with a fast ADC and numerically integrated by an FPGA. The field integral is then distributed to the users every time that the equivalent field changes by 0.1 G. The measured B field ranges from 0 to 1.6 T with maximum ramps of 3 T/s. The B-train system will be used to provide feedback in field to the dipole power supply. It will handle the limited bandwidth of the active filter, the B-field lag in the magnets and will avoid current jumps.

THPS066	Technical Overview of the SIEMENS Particle Therapy Accelerator	3577
	V. Lazarev, O. Chubarov, S. Emhofer, G. Franzini, S. Göller, B. Nagorny, A. Robin, H. Rohdjess, R. Rottenbach, A.C. Sauer, R. Schedler, T. Sieber, B. Steiner, J. Tacke, D.B. Thorn, T. Uhl, P. Urschütz, O. Wilhelmi Siemens Med, Erlangen, Germany M. Budde, J.S. Gretlund, H.B. Jeppesen, C.V. Nielsen, C.G. Pedersen, Ka.T. Therkildsen, S.V. Weber Siemens DK, Jyllinge, Denmark
	Siemens has developed an accelerator system for particle therapy. It consists of an injector (7 MeV/u protons and light ions) and a compact synchrotron able to accelerate proton beams up to 250 MeV and carbon ions up to 430 MeV/u. These beams are extracted slowly from the synchrotron and delivered to a number of beam ports. The first accelerator system has been built and commissioned up to the first two beam outlets. An overview of the achieved performance of the system is presented. *Particle therapy is a work in progress and requires country-specific regulatory approval prior to clinical use.

Paper

Title

Page

B-train Performances at CNAO

568

M. Pezzetta, G. Bazzano, E. Bressi, L. Falbo, C. Priano, M. Pullia
CNAO Foundation, Milan, Italy
O. Coiro, G. Franzini, D. Pellegrini, M. Serio, A. Stella
INFN/LNF, Frascati (Roma), Italy
G. Venchi
University of Pavia, Pavia, Italy

The commissioning of CNAO, the Italian Centre of Oncological Hadrontherapy, with proton beams is completed. The real-time measurement of the synchrotron dipole field with the so-called B-train, together with its electronic systems and related software and firmware are here described. An additional magnet, powered in series with the synchrotron dipoles, is equipped with a special coil that measures the field integral variation along the beam nominal path. The voltage induced in the coil is digitized with a fast ADC and numerically integrated by an FPGA. The field integral is then distributed to the users every time that the equivalent field changes by 0.1 G. The measured B field ranges from 0 to 1.6 T with maximum ramps of 3 T/s. The B-train system will be used to provide feedback in field to the dipole power supply. It will handle the limited bandwidth of the active filter, the B-field lag in the magnets and will avoid current jumps.

THPS066

Technical Overview of the SIEMENS Particle Therapy Accelerator

3577

V. Lazarev, O. Chubarov, S. Emhofer, G. Franzini, S. Göller, B. Nagorny, A. Robin, H. Rohdjess, R. Rottenbach, A.C. Sauer, R. Schedler, T. Sieber, B. Steiner, J. Tacke, D.B. Thorn, T. Uhl, P. Urschütz, O. Wilhelmi
Siemens Med, Erlangen, Germany
M. Budde, J.S. Gretlund, H.B. Jeppesen, C.V. Nielsen, C.G. Pedersen, Ka.T. Therkildsen, S.V. Weber
Siemens DK, Jyllinge, Denmark

Siemens has developed an accelerator system for particle therapy. It consists of an injector (7 MeV/u protons and light ions) and a compact synchrotron able to accelerate proton beams up to 250 MeV and carbon ions up to 430 MeV/u. These beams are extracted slowly from the synchrotron and delivered to a number of beam ports. The first accelerator system has been built and commissioned up to the first two beam outlets. An overview of the achieved performance of the system is presented.
*Particle therapy is a work in progress and requires country-specific regulatory approval prior to clinical use.